Загрузка...
Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action
INTRODUCTION: MDD represents a significant burden worldwide, and while a number of approved treatments exist, there are high rates of treatment resistance and refractoriness. Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist, is a novel, rapid-acting antidepressant, however the mechanism...
Сохранить в:
| Опубликовано в: : | Ment Health Clin |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
College of Psychiatric & Neurologic Pharmacists
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120982/ https://ncbi.nlm.nih.gov/pubmed/34026396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2021.05.200 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|